Ramification of Covid-19 pandemic : Occurrence and impact of fungal Infections in a tertiary care hospital
Diagnosis and Management of Fungal Infections
Immunology
Infectious disease (medical specialty)
FOS: Health sciences
Applied Microbiology and Biotechnology
Biochemistry
Food science
Global Burden of Antimicrobial Resistance
Health Sciences
Rhizopus arrhizus
Pathology
Mucormycosis
Aspergillosis
Tuberculosis
Disease
Internal medicine
Biology
Immunology and Microbiology
Pharmacology
Pandemic
FOS: Clinical medicine
Gastroenterology
Sputum
Life Sciences
Scientific and Medical Aspects of Ozone Therapy
Lipase
Medical microbiology
3. Good health
Coronavirus disease 2019 (COVID-19)
Infectious Diseases
Enzyme
Galactomannan
Fermentation
Medicine
Antifungal Resistance
Rhizopus
DOI:
10.1099/acmi.0.000640.v1
Publication Date:
2023-06-08T17:29:27Z
AUTHORS (6)
ABSTRACT
Coronavirus disease 2019 (Covid-19) pandemic has been prevailing for more than a year associated with increased number of opportunistic invasive fungal infections in patients who have been critically ill or immunocompromised. In this retrospective study, details of various clinical specimens received from suspected patients of fungal infections were processed according to standard protocol were studied. The fungal infections were present in 64% (51/79) COVID-19 positive patients and 43% (163/381) COVID-19 negative patients) during the year 2021 during the second wave of COVID-19. Among Covid infected patients, the fungal infection mostly observed was Candidiasis (63%) followed by Aspergillosis (15% ) and Mucormycosis (6%). The maximum samples positive in Covid patients were urine samples followed by Serum (for Aspergillus Galactomannan). Among the urine and respiratory samples (BAL, Tracheal aspirate, Sputum) in Covid-19 positive patients, maximum positivity of Candida species was seen. Mucormycosis in Covid-19 positive patients was isolated in Nasal samples followed by tissue sample with Rhizopus arrhizus and Rhizopus homothallicus. There has been an increase in fungal co-infections during the COVID-19 pandemic which is a matter of great concern. Early diagnosis is essential for effective management of these patients.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....